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Abstract: Reduced early microbial exposure in early life has become
a leading candidate to explain the escalating rate of allergic disease
and has generated intense interest in the interaction between the
developing immune system and the microbial environment. Infants
depend on Bsignals[ from the microbial environment to mature both
T-helper cell type 1 and regulatory immune function. These signals,
mediated through microbial pattern-recognition receptors, namely
toll-like receptors (TLRs), seem essential to achieving the immuno-
logic balance required for (1) pathogen protection and (2) normal
immune tolerance. Despite this, the normal development of TLR
function has never been documented. There is preliminary evidence
that TLR function is under the influence of both genetic factors
(genetic polymorphisms) and early environmental exposures includ-
ing microbial exposure and breast feeding, and maternal smoking.
This review explores the evidence that allergy is associated with
developmental variations in TLR-mediated immune function and
how this may be relevant for disease prevention.
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The epidemic rise in asthma and allergic disease during thelast 40 years highlights the urgent need to identify the
developmental pathways that lead to disease. Although this
rise in allergic disease is likely to be multifactorial, one of the
most plausible candidates has been the apparent decline in
microbial burden in early life. A better understanding of the
links between innate immune and cognate (allergen-specific)
immune development is the logical next step in the quest to
define allergy pathogenesis. There is escalating interest in the
pathways that influence maturation of the key cells involved in
early immune regulation, namely antigen-presenting cells
(APCs) and regulatory T cells. These cells depend on toll-like
receptor (TLR)Ymediated signaling for activation and matura-
tion, and there is growing speculation that both genetic
polymorphisms (affecting TLR function) and environmental
factors (such reduced microbial exposure) predispose to
allergic disease through effects on innate immune pathways.
Better understanding of the development of these pathways is
also likely to contribute to more avenues for better targeted
treatment and prevention.
This review explores the evidence to support the
emerging hypothesis that:
1. There is normal age-related maturation of TLR-mediated
innate immune pathways, and genetic predisposition and
early environmental exposures result in individual varia-
tions in the rates of maturation and functional patterns;
2. Altered maturation in TLR-mediated responses are
associated with effects on antigen-specific immune
responses (including increased predisposition for T-helper
cell type 2 (Th2) allergic responses to allergens); and
3. Children who develop allergy show differences in early
maturation of TLR-mediated responses.
THE ROLE OF MICROBIAL STIMULATION
FOR EARLY IMMUNE DEVELOPMENT
The current paradigm maintains that immature Th2Y
dominant neonatal responses must undergo environment-
driven maturation in the early postnatal period,1,2 with gradual
inhibition of this early Th2 propensity in favor of more mature
Th1 dominant responses. Although the responsible factors are
still unclear, experimental models3 have provided strong
support for the hypothesis that early microbial exposure is
critical for normal development (reviewed in Strachan4 and
Prescott5). As the most powerful immunostimulants in the
normal environment, these agents generally activate the innate
immune system to promote host defense through Th1 effector
function.
THE ROLE OF TLR PATHWAYS
IN IMMUNE REGULATION
Toll-like receptors are essential to first-line innate
defense mechanisms that have evolved to recognize bacteria,
viruses, and other microorganisms in the potential absence of
established immunologic Bmemory.[ This family of receptors
recognize a broad range of microbial agents6 with different
TLR signaling the presence of different micobial components.
The TLRs are found on many cells involved in immediate host
defense such as neutrophils, natural killer cells, and APCs,
which also play a critical role in programming subsequent
adaptive T-cell responses. Once activated via these TLR
pathways, dendritic cells and other APCs show enhanced
expression of costimulatory molecules and cytokines (includ-
ing interleukin 12 [IL-12]), which favor Th1 immune
differentiation. More recently, TLRs (TLRs 4, 5, 7, and 8)
have also been identified on CD4+ CD25+ T-regulatory cells7
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that play a critical role in controlling immune responses.8 Thus,
it has been proposed that TLR-mediated activation of
both APC and regulatory T cells may play an important
role in reducing the risk of Th2-mediated allergic responses
(Wills-Karp et al,8 Holt et al,9and others). This is obviously of
most relevance in early life when programming of immuno-
logic function is initiated. Despite this, the ontogeny of TLR
function has not been documented.
There is growing speculation that TLR function matures
in the postnatal period and that children who develop allergic
disease have differences in these development patterns as a
result of genetic predisposition and/or environmental influ-
ences. This hypothesis is based on preliminary evidence that:
a. TLR function is developmentally regulated, with differ-
ences between infants and adults; and that
b. genetic and environmental factors can modify TLR
function in early life, as discussed later.
PRELIMINARY EVIDENCE THAT TLR FUNCTION
IS DEVELOPMENTALLY REGULATED
Although there are no longitudinal studies of TLR
development in the early postnatal period, our preliminary
studies show significantly lower TLR-mediated responses in
neonates (cord blood) compared with adults (as shown on
Fig. 1). In these studies, we used TLR2 (pansorbin) and TLR4
(lipopolysaccharide [LPS]) ligands to activate these innate
pathways, with cytokine detection as a measure of pathway
function. The production of inflammatory cytokine (tumor
necrosis factor-> [TNF->]) and regulatory cytokine (IL-10)
was attenuated in the neonates. This was also seen for IL-6
(P = 0.045, not shown). This is consistent with other reports
demonstrating differences in TLR function between neonates
and adults.10,11 We have also reported functional differences in
neonatal responses to TLR9 ligands (microbial cytosine-
phosphate-guanine [CpG] motifs) compared with adults.12
Finally, others have shown age-related increases in the levels
of circulating soluble (s)CD14, which is involved in TLR4
signaling.13 Together, these observations strongly support the
hypothesis that TLR responses mature in the postnatal period.
PRELIMINARY EVIDENCE THAT TLR FUNCTION
IS INFLUENCED BY EARLY EVENTS
There is also emerging evidence that TLR function (and
maturation of function) is regulated by both genetic and en-
vironmental factors.
Evidence That TLR Function Is Influenced by
Genetic Factors
Genetic polymorphisms in TLR have been shown to
confer variability in functional responses. The TLR4 poly-
morphisms have been associated with LPS hyporesponsive-
ness14 and variations in LPS-induced IL-12 and IL-10
responses.15 Familial allergy risk (maternal allergy) has also
been associated with reduced neonatal TLR2 responses (p =
0.03; n = 9), and lower TLR2, TLR4, and CD14 messenger
RNA levels in cord blood (n = 185).16Y18 This has led to
speculation that inherited predisposition to TLR immaturity
may contribute to less effective TLR-mediated inhibition of
allergic responses. However, findings of a recent cohort study
by our group contradict this. Instead, we observed that high-
risk infants (n = 59) had significantly higher (rather than lower)
responses to TLR2, TLR3, and TLR4 ligands (particularly
IL-12 responses) than low-risk infants (n = 52; shown for
TLR4 on Fig. 2) (M. Tulic, P. Noakes, B. Chow, et al.,
unpublished data, 2008). Although the relevance of this is not
clear, these observations do suggest that genetic factors may
lead to differential expression and function of these pathways.
Evidence That TLR Function Can Be Altered
by Early Environmental Exposures
Microbial exposure is likely to be a major factor
influencing TLR function. Intrauterine infection has been
associated with increased placental TLR(4) expression,19
however, the effects of variation in ambient microbial
exposure are less clear. Some studies suggest that TLR
expression (level of receptor detected) is related to maternal
LPS exposure pregnancy,20 whereas others show that high
exposure is associated with significant down-regulation of
responses to TLR ligands (LPS) that were notably also
associated with less allergic disease and sensitization.21 These
apparently divergent findings could relate to differences in
FIGURE 1. Comparison of neonatal and adult responses to TLR
activation: TNF-> and IL-10 responses were measured after
stimulation with a TLR2 ligand (pansorbin) and TLR4 ligand
(LPS). The cytokine levels in culture supernatants (picograms
per milliliter) after 48 hours are displayed as median, and 5, 25,
75, and 95 percentile ranges and outlying values. All responses
are shown as the levels in stimulated cultures after subtracting
levels in the unstimulated control cultures. Data from adults
(shaded bars) were compared with neonates (unshaded bars)
using nonparametric Mann Whitney U test (with significance
values as shown).
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measuring levels versus function. Although more studies are
needed to determine the significance, these findings do suggest
that early microbial exposure can modify innate receptor
expression and function.
A number of other environmental exposures have been
associated with TLR expression. Human milk (as opposed to
formula milk) has been associated with differential TLR
expression (with down-regulation of TLR2 and TLR3 function
and up-regulation of TLR4 and TLR5).22 The relationship
between these immunomodulatory effects and the immunopro-
tective properties of breast milk are not yet clear. Recent studies
also indicate that the immunomodulatory properties of n-3
polyunsaturated fatty acids (fish oil) are mediated, at least in
part, through TLR4.23 Finally, we have recently shown that
specific exposures in pregnancy (such as maternal smoking) are
associated with significantly reduced TLR function24; with
effects on TLR2, -3, -4, and -9 function.25 There were no effects
with other (non-TLRYmediated) methods of stimulation (such
as phytohemagglutinin mitogen), suggesting selective effects on
TLR signaling (possibly through common signal transduction
pathways such as activator protein 1 or nuclear factor-JB.
Together, these observations suggest that TLR function is
influenced by both genetic and environmental exposures in early
life, providing a strong basis for our hypothesis that these
variationswill have effects on subsequent immune development.
EVIDENCE THAT VARIATIONS IN TLR FUNCTION
COULD INFLUENCE DEVELOPMENT
OF ALLERGEN-SPECIFIC RESPONSES OR THE
RISK OF ALLERGIC DISEASE
Although this has not been examined directly in
humans, genetic studies provide supportive evidence that
functional variations in aspects of TLR microbial signaling are
associated with clinical phenotypes and disease. Specifically,
polymorphisms in the gene coding for CD14 have been linked
to total serum immunoglobulin E levels,25 suggesting
functional relationship between atopy and TLR4 pathways.
Some more recent studies have shown that TLR4 genetic
polymorphisms have a protective effect on asthma,15 but
others have not.26,27 The TLR2 genetic polymorphisms have
also been shown to have a protective effect on asthma.28
Notably, the protective effect was only seen when children
were raised in environments with Bhigh[ microbial burden,
illustrating the interactive effects of genetic and environmental
factors on these pathways. Together, these findings suggest
that alterations in TLR function, either as a result of
differences in early environmental exposures or functional
genetic polymorphisms, have an effect on subsequent
development of adaptive immune function.
As part of our recent TLR studies, we compared neonatal
TLR function according to subsequent allergic outcomes in the
first year of life (diagnosed as food allergy or atopic dermatitis),
and noted that the nonallergic group (n = 74) had lower TLR-
mediated responses than the allergic group (n = 28).19 These
were most notable in response to TLR3 ligands (significantly
lower TNF-> and IL-12 responses) and TLR5 ligands
(significantly lower TNF-> and IL-10 responses), although
similar trends were seen with other ligands. This seemingly
paradoxical observation that lower TLR responses are
protective is consistent with observations that the protective
effects of microbial exposure are also associated with down-
regulated TLR-mediated microbial responses.22 The signifi-
cance and mechanisms of these relationships remain to be
determined. Thus, whereas alterations in TLR function seem to
be associated with the development of allergic disease, the
FIGURE 2. Comparison of TLR4-mediated responses in neonates at high and low risk of allergy (based on maternal allergy):
interferon-F and IL-12 responses were measured after stimulation with TLR4 ligand (LPS). The cytokine levels in culture supernatants
(picograms per milliliter) after 48 hours are displayed as median, and 5, 25, 75, and 95 percentile ranges and outlying values. All
responses are shown as the levels in stimulated cultures after subtracting levels in the unstimulated control cultures. Data from high-
risk neonates (shaded bars) were compared with low-risk neonates (unshaded bars) using nonparametric Mann Whitney U test.
Significance values are shown as *p G 0.01; **p G 0.05.
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initial hypothesis (that reduced TLR function predisposes to
allergic disease) seems oversimplistic.
EVIDENCE THAT TLR ACTIVATION COULD BE A
WAY TO REDUCE THE RISK OF ALLERGY
A number of studies suggest that early microbial-driven
TLR activation may modify immune development and the risk
of sensitization. In an animal model, Blumer et al29 recently
demonstrated that antenatal (maternal) exposure to bacterial
LPS enhanced neonatal Th1 interferon-F responses and
inhibited (ovalbumin) allergen sensitization in the offspring.
This demonstrates that immune activation via the TLR4
pathway can modify allergen-specific immune development.
Tulic et al30 have shown similar effects of this TLR4 ligand
(LPS) in the postnatal period, but notably, the inhibition of
allergic responses was seen only when LPS was given before
responses were established. There is only indirect evidence
that early bacterial exposure may be protective in humans.
This includes the many epidemiological studies (reviewed by
Strachan4) that formed the basis of the Bhygiene hypothesis.[
Intervention studies also suggest that administration of
bacterial products to children may have clinical (Arkwright
and David,31 Weston et al,32 and others) and immune effects.33
Although it has been inferred that these variations in microbial
exposure may be responsible for differences in innate (and
subsequent cognate) immune function, this has not been
documented directly.
The main intervention studies that use microbial
products to prevent allergic disease in humans have used
nonpathogenic probiotic species. At least some of the anti-
inflammatory effects seem to be mediated through TLR,
including TLR934 and possibly TLR2 and TLR4 expressed on
enterocytes. These flora have been shown to promote
regulatory populations35 and tolerogenic dendritic cells36Y38
to promote Th1 differentiation.
39 Initial clinical studies showed
promising results in the prevention of allergic disease
(although this was limited to atopic dermatitis),40 however,
not all subsequent studies have shown a benefit.41,42 This may
be caused by differences in the species, dose and timing of
supplementation, and other host and environmental factors. It
remains likely that microbial products could have a role in
disease prevention, although more targeted and more refined
strategies may need to be developed before this is possible. A
better knowledge of TLR ontogeny and the effects of
functional genetic polymorphisms on treatment response will
be essential to this process.
In summary, infants seem to depend on signals from the
microbial environment to mature both Th1 and regulatory
immune function. These signals, mediated through pattern-
recognition receptors such as TLR, seem essential to achieving
the immunologic balance required for (1) pathogen protection
and (2) normal immune tolerance. It is therefore highly logical
to further investigate the potential role of impaired TLR
signaling in the development of allergic disease. The current
evidence supports the notion that genetic and environmental
factors can result in early variations in TLR function, and that
this can affect adaptive immune development. Further studies
are needed to assess normal ontogeny of TLR function and to
assess differences in atopic infants. This should lead to a better
understanding of the role of bacterial products in prevention or
early treatment, and how genetic factors may influence
individual differences in responsiveness to potential interven-
tion strategies.
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